Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Carcinoma Metastatic × Lenalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 383 Lymphoma, Large B-Cell, Diffuse 91 Leukemia, Lymphocytic, Chronic, B-Cell 79 Lymphoma, Follicular 74 Recurrence 64 Lymphoma 55 Lymphoma, Mantle-Cell 53 Neoplasms, Plasma Cell 51 Lymphoma, B-Cell, Marginal Zone 46 Lymphoma, Non-Hodgkin 41 Leukemia, Myeloid, Acute 32 Leukemia 29 Myelodysplastic Syndromes 23 Lymphoma, B-Cell 22 Neoplasms 21 Waldenstrom Macroglobulinemia 17 Smoldering Multiple Myeloma 16 Hodgkin Disease 15 Burkitt Lymphoma 14 Lymphoma, T-Cell, Peripheral 13 Lymphoma, T-Cell, Cutaneous 12 Prostatic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Sezary Syndrome 10 Mycosis Fungoides 10 Hematologic Diseases 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell 8 Lymphoma, Large-Cell, Anaplastic 8 Leukemia, Myelomonocytic, Chronic 8

Interventions

Lenalidomide 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01547260 2022-08-22

LENAGEM

Karolinska University Hospital

Phase 1/2 Completed

Gastrointestinal

Pancreatic Carcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡